High Tower Advisors, LLC Compugen LTD Transaction History

High Tower Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.66 - $2.32 $8,514 - $29,927	12,900 Added 52.65%	37,400 $23,000
Q4 2021 Feb 10, 2022	BUY	$4.09 - $7.16 $10,225 - $17,900	2,500 Added 11.36%	24,500 $106,000
Q3 2021 Nov 12, 2021	SELL	$5.8 - $8.02 $17,400 - $24,060	-3,000 Reduced 12.0%	22,000 $131,000
Q2 2021 Aug 06, 2021	SELL	$6.87 - $9.16 $680 - $906	-99 Reduced 0.39%	25,000 $207,000
Q1 2021 May 10, 2021	BUY	$7.67 - $13.77 $30 - $55	4 Added 0.02%	25,099 $216,000
Q4 2020 Feb 10, 2021	SELL	$12.07 - $17.95 $482 - $718	-40 Reduced 0.16%	25,095 $303,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $28 - $38	2 Added 0.01%	25,135 $409,000
Q2 2020 Aug 10, 2020	BUY	$6.97 - $17.12 $175,177 - $430,276	25,133 New	25,133 $377,000

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.